Anke Biology establishes a new company incorporating human genetic diagnosis and treatment services.

According to the Enterprise Check APP, Jiangsu Anyong Jie Life Science and Technology Co., Ltd. was recently established with a registered capital of 40 million RMB. Their business scope includes research and development of biological materials technology, manufacturing of biological materials, and development of human genetic diagnosis and treatment technology. According to equity penetration information from Enterprise Check, the company is fully owned by Anke Biotechnology.